Posted on 11/13/19
Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib
Armas Pharmaceuticals Inc. is announcing the launch of generic Tarceva Tablets. Erlotinib is now available in 25mg, 100mg and 150mg strengths. This is Armas' third oral . . .
Posted on 11/13/19
Risalto Health Raises $7M
Risalto Health, a digital health services company transforming the delivery of musculoskeletal (MSK) care, has raised $7M in capital from New York-based Health Catalyst
Posted on 11/13/19
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
No matter how you look at it, Bristol-Myers Squibb (NYSE:BMY) claims an attractive dividend. Its yield currently stands north of 2.8%. The big pharma company has . . .
Posted on 11/12/19
HealthCare.com Ranked Number 155 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500
NEW YORK--(BUSINESS WIRE)--6, a leader in technology-enabled health insurance solutions, today announced it ranked No. 155 on Deloitte’s Technology Fast 500™, a ranking of the 500 . . .
Posted on 11/12/19
Better Buy: Biogen vs. Celgene
You probably won't find two bigger stories in the world of biotech in 2019 than those of Biogen (NASDAQ:BIIB) and Celgene (NASDAQ:CELG). Biogen's lead pipeline candidate, . . .
Posted on 11/12/19
Why Bristol-Myers Squibb Stock Gained 13% in October
What happenedBiopharma titan Bristol-Myers Squibb (NYSE:BMY) saw its shares gain 13% in October, according to data from S&P Global Market Intelligence.What sparked this sizable rally in . . .
Posted on 11/12/19
Bioasis Completes Financing Transactions
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the . . .
Posted on 11/8/19
Citius Pharmaceuticals Issues Corporate Update
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that the Company has issued . . .
Posted on 11/8/19
Advocare Welcomes Seven New Independent Physician Practices
Advocare, a physician-owned multi-specialty group with nearly 600 providers, has expanded its footprint in New Jersey and Pennsylvania by welcoming seven new independent physician practices into . . .
Posted on 11/7/19
Zoetis Announces Third Quarter 2019 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2019 and updated its guidance for full year 2019.The company . . .
Posted on 11/6/19
Amneal Reports Third Quarter 2019 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the third quarter ended September 30, 2019.Net revenue in the third quarter of 2019 was . . .
Posted on 11/6/19
Enhanced Healthcare Partners and Bourne Partners Strategic Capital Announce Investment in Pharmaceutical Associates
NEW YORK--(BUSINESS WIRE)--Enhanced Healthcare Partners, a leading New York-based private equity firm focused on investing in middle-market healthcare businesses, together with Bourne Partners Strategic Capital, a . . .
Posted on 11/6/19
Cara Therapeutics Reports Third Quarter 2019 Financial Results
STAMFORD, Conn., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 11/6/19
Regeneron Pharmaceuticals Tops Q3 Estimates Thanks to Soaring Sales of 2 Drugs
Regeneron Pharmaceuticals (NASDAQ:REGN) could use some more good news. The company has picked up some key regulatory approvals for additional indications for its drugs in recent . . .
Posted on 11/5/19
Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 . . .
Posted on 11/5/19
pCare Partners with Redox
pCare has entered into a new partnership with Redox, a leading cloud interoperability platform that standardizes data exchange across the technology solutions used by healthcare organizations. The . . .
Posted on 11/5/19
Innovative Management Solutions New York Partners with Arcadia.io
Population health management leader Arcadia (www.arcadia.io) announced today a partnership with Innovative Management Solutions (IMSNY), a joint venture between Coordinated Behavioral Care (CBC) and Coordinated Behavioral . . .
Posted on 11/5/19
Intercept Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to . . .
Posted on 11/5/19
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results
EWING, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the third quarter ended September 30, . . .
Posted on 11/5/19
Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced financial . . .
Posted on 11/5/19
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics
SummaryThe following is a detailed excerpt of an interview conducted over email with the CEO of Brainstorm Cell Therapeutics, Chaim Lebovits.This interview follows from an article . . .
Posted on 11/4/19
Cosette Pharmaceuticals Announces the Acquisition of G&W Laboratories' Lincolnton, NC Finished Dosage Manufacturing Plant
Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products,
Posted on 11/4/19
Amulet Capital’s OPEN Health Merges with Pharmerit International
Transaction creates the leading provider of HEOR, market access, medical affairs and healthcare communications services to pharmaceutical companies across US, Europe and Asia LONDON & BETHESDA, . . .
Posted on 11/4/19
Johnson & Johnson's Xarelto Gains Another FDA Approved Indication, Needs Additional Nods Under Its Belt
SummaryJohnson & Johnson received FDA approval for its drug Xarelto to treat blood clot patients with acute illness who are either hospitalized or discharged from the . . .
Posted on 11/4/19
Ovid Therapeutics Announces Senior Management Promotions
NEW YORK, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people . . .
New York
